Cargando…

Evaluating Risks, Costs, and Benefits of New and Emerging Therapies to Optimize Outcomes in Multiple Sclerosis

BACKGROUND: Multiple sclerosis (MS) is a complex, chronic, and often disabling neurological disease. Despite the recent incorporation of new treatment approaches early in the disease course, care providers still face difficult decisions as to which therapy will lead to optimal outcomes and whento in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandari, Daniel S., Sternaman, Debora, Chan, Theodore, Prostko, Chris R., Sapir, Tamar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2012
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437431/ https://www.ncbi.nlm.nih.gov/pubmed/23206263 http://dx.doi.org/10.18553/jmcp.2012.18.S9-B.1

Ejemplares similares

Managed Approaches to Multiple Sclerosis in Special Populations
por: Sperandeo, Kara, et al.
Publicado: (2011)

Current and Future Directions in MS Management: Key Considerations for Managed Care Pharmacists
por: Lipsy, Robert J., et al.
Publicado: (2009)

Methods for Insulin Delivery and Glucose Monitoring in Diabetes: Summary of a Comparative Effectiveness Review
por: Golden, Sherita Hill, et al.
Publicado: (2012)

LMD-09. Outcomes and symptom benefit from palliative radiotherapy for leptomeningeal disease in breast cancer patients
por: Takayesu, Jamie, et al.
Publicado: (2021)

Review of the Clinical Debate Regarding Interventions for Multiple Sclerosis
por: Ryan,, Melody, et al.
Publicado: (2009)

Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
por: Ruderman, Eric M., et al.
Publicado: (2012)

Optimizing Dyslipidemia Outcomes
por: Lipsy, Robert J., et al.
Publicado: (2003)

From Adherence to Outcomes: Impact of Benefit Design on the HIV Patient
por: Chao, Schumarry H., et al.
Publicado: (2006)

Anticipating the Future: How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

Exploring New Frontiers in Asthma Management for Optimal and Economic Outcomes
por: Meltzer, Eli O., et al.
Publicado: (2003)

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence
por: Patti, Francesco
Publicado: (2010)

Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David, et al.
Publicado: (2007)

The Impact of Diabetes and Associated Cardiometabolic Risk Factors on Members: Strategies for Optimizing Outcomes
por: Hoerger, Thomas J., et al.
Publicado: (2008)

Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
por: Wykoff, Charles C., et al.
Publicado: (2018)

The Unhidden Cost of Noncompliance
por: Mahoney, John J., et al.
Publicado: (2008)

Managing Patients With Chronic Angina: Emerging Therapeutic Options for Improving Clinical Efficacy and Outcomes
por: Dobesh, Paul P., et al.
Publicado: (2006)

Comment — WHO outsourcing dilemma: for whose benefit, at whose expense?
por: Sharma, Jeevan Raj, et al.
Publicado: (2017)

Exploring the benefits and challenges of establishing a DRI-like process for bioactives
por: Lupton, Joanne R., et al.
Publicado: (2014)

A Fortified Food Can Be Replaced by Micronutrient Supplements for Distribution in a Mexican Social Protection Program Based on Results of a Cluster-Randomized Trial and Costing Analysis
por: Neufeld, Lynnette M, et al.
Publicado: (2019)

“This Drug May Work, But Is It Worth the Cost?” Can Comparative Effectiveness Research Help Tame Rising Health Care Costs?
por: Brixner, Diana I., et al.
Publicado: (2012)

Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases
por: Kalden, Joachim R
Publicado: (2002)

Opioid Dependence: Managing the High Cost of Treatment Failure
por: Jan, Saira A.
Publicado: (2010)

Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease
por: Rao, Vamshi K., et al.
Publicado: (2018)

Shifting the Focus From Cost to Value: Key Stakeholder Perspectives
por: Chao, Schumarry H., et al.
Publicado: (2006)

The Role of Pharmaceuticals in Reducing Cardiometabolic Risk: Rethinking Pharmacy Benefit Design to Reduce the Burden on the Health Care System
por: Chao, Schumarry H., et al.
Publicado: (2006)

Estimates of HIV burden in emergencies
por: Lowicki-Zucca, M, et al.
Publicado: (2008)

Women’s health: optimal nutrition throughout the lifecycle
por: Feskens, Edith J. M., et al.
Publicado: (2022)

Multiple meningiomas: Epidemiology, management, and outcomes
por: Fahlström, Andreas, et al.
Publicado: (2023)

Perspectives for Managed Care Organizations on the Burden of Multiple Sclerosis and the Cost-Benefits of Disease-Modifying Therapies
por: Owens, Gary M., et al.
Publicado: (2013)

Burden of Illness: Costs and Consequences of Our Fragmented Mental Health Care System
por: Arizpe, Michael, et al.
Publicado: (2006)

Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy
por: Gernez, Yael, et al.
Publicado: (2018)

Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids
por: Harrington, Amanda, et al.
Publicado: (2020)

Mild-to-Moderate Ulcerative Colitis: Your Role in Patient Compliance and Health Care Costs
por: Tindall, William N., et al.
Publicado: (2007)

Biosimilars: Opportunities to Promote Optimization Through Payer and Provider Collaboration
por: Manolis, Chronis H., et al.
Publicado: (2016)

Targeted, Evidence-Based Colorectal Cancer Therapies: Shifting the Patient Outcome
por: Benson, Al, et al.
Publicado: (2007)

Optimal nutrition and the ever-changing dietary landscape: a conference report
por: Shao, A., et al.
Publicado: (2017)

Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)

Summary of AHRQ’s Comparative Effectiveness Review of Treatment to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis: Update of the 2007 Report
por: Levis, Silvina, et al.
Publicado: (2012)

Comparative Cost Analysis of Surgical and PrePex Device Male Circumcision in Zimbabwe and Mozambique
por: Schutte, Carl, et al.
Publicado: (2016)

Costs and benefits of realism and optimism
por: Bortolotti, Lisa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sgcroef03lltvek9lud6gb9qec